Marvell Downgraded as Tower Sector Targets Rise
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Analysts downgraded MRVL on Tuesday, trimming the consensus target to $327.36 from $333.09. The chipmaker lost one Buy rating, leaving 39 Buys and 5 Holds against zero Sells. Marvell has been a favourite AI infrastructure play, so the change will attract attention.
SBAC saw the biggest consensus target lift of the session. The cell tower REIT's average target rose to $225.75 from $225.25, with 10 Buy and 11 Hold ratings and no Sells. Tower stocks have benefited from steady carrier spending on 5G densification.
AAPL picked up a small target increase, moving to $333.28 from $332.39. The consensus is weighted heavily toward Buys, with 24 Buy, 13 Hold and 5 Sell ratings.
GEHC also saw its target nudge higher, to $87.85 from $86.80. GE HealthCare holds 15 Buys and 6 Holds.
Among hotels, MAR received a meaningful target upgrade to $400.00 from $393.35. Marriott carries 13 Buys and 14 Holds. India domestic auto sales rose 24% year-on-year in October, which points to broader consumer strength in Asia that could support international travel demand.
On the downside, ARE saw its target cut to $49.93 from $50.43. The life-science REIT has faced persistent pressure as biotech tenants pull back. ON also had its target trimmed slightly to $100.00 from $101.16, with the Buy-to-Hold split sitting at 15 each.
QCOM bucked semiconductor headwinds with a target lift to $197.21 from $195.97, supported by 23 Buy ratings.
Stocks in this article
How this article was generated
- Generated
- 3 Nov 2026, 16:21
- Prompt version
- v1.0
- Data sources
- Analyst consensusAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.